@article{6ba74305509640bf8ffb29b024c159df,
title = "The North-South divide: Substance use risk, care engagement, and viral suppression among hospitalized human immunodeficiency virus-infected patients in 11 US cities",
abstract = "Regional variability in human immunodeficiency virus (HIV) care engagement remains underexplored. Multiple logistic models compared HIV outcomes for participants from 5 Southern (n = 557) and 6 non-Southern (n = 670) sites. Southern participants were less likely to experience viral suppression (adjusted odds ratio [aOR], 0.52; 95% confidence interval [CI],.37-.72) and had a higher likelihood of a CD4+ count <200 cells/μL (aOR, 1.53; 95% CI, 1.17-2.00). HIV intervention and social safety net programs should be expanded. Clinical Trials Registration NCT01612169.",
keywords = "HIV care continuum, care engagement, geographic disparities, substance use, viral suppression",
author = "Philbin, {Morgan M.} and Feaster, {Daniel J.} and Lauren Gooden and Rui Duan and Moupali Das and Petra Jacobs and Lucas, {Gregory M.} and Batey, {D. Scott} and Nijhawan, {Ank E} and Jacobson, {Jeffrey M.} and Raul Mandler and Eric Daar and McMahon, {Deborah K.} and Armstrong, {Wendy S.} and {Del Rio}, Carlos and Metsch, {Lisa R.}",
note = "Funding Information: Potential conflicts of interest. E. S. D. receives research support from Gilead, Merck, and ViiV and is a consultant/advisor for Bristol-Myers Squibb, Gilead, Janssen, Merck, Theratechnologies, Teva, and ViiV. M. D. is an employee of Gilead Sciences and owns stock in the company. A. N. has received grants from Gilead. All other authors report no potential conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. Funding Information: Financial support. This work was supported by the National Institute on Drug Abuse (NIDA) under the following awards: U10DA013720 and UG1DA013720 to Dr Jos{\'e} Szapocznik and L. R. M.; U10DA013035 and UG1DA013035 to Drs John Rotrosen and Edward V. Nunes, Jr; U10DA013034 and UG1DA013034 to Drs Maxine Stitzer and Robert Schwartz; U10DA013727 and UG1DA013727 to Drs Kathleen T. Brady and Matthew Carpenter; U10DA020024 and UG1DA020024 to Dr Madhukar H. Trivedi; U10DA013732 and UG1DA013732 to Dr Theresa Winhusen; U10DA015831 and UG1DA015831 to Drs Roger D. Weiss and Kathleen Carroll; U10DA015815 and UG1DA015815 to Drs James L. Sorensen and Dennis McCarty; U10DA020036 to Dr Dennis Daley; U10DA013043 to Dr. George Woody; U10DA013045 to Dr Walter Ling; N01DA142237 to Dr Paul VanVeldhuisen; N01DA102221 to Dr Robert Lindblad; K01DA039804A to M. M. P.; and K24DA035684 and P30AI094189 to G. M. L. This work was also supported by the University of Miami Center for AIDS Research (CFAR) (award number P30AI073961 to Dr Savita Pahwa); the Emory University CFAR (award number P30AI050409 to C. d. R., Drs James W. Curran and Eric Hunter); and the Atlanta Clinical and Translational Science Institute (award number UL1TR000454 to Dr David Stephens). A. N. and R. D. have received grants from the National Institutes of Health. D. K. M. has received grants from the University of Pittsburgh. L. G. and J. M. J. have received grants from NIDA. Publisher Copyright: {\textcopyright} 2018 The Author(s). Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved.",
year = "2019",
month = jan,
day = "1",
doi = "10.1093/cid/ciy506",
language = "English (US)",
volume = "68",
pages = "146--149",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "1",
}